The Korea Times
A court ruling has partly curbed Samsung Biologics labor union’s plan to stage an all-out strike, in a move seen as undermining its momentum. The Incheon District Court on Thursday partially granted Samsung Biologics’ injunction request against the strike planned for May 1. In its ruling, the court rejected the biopharmaceutical firm’s request to ban the strike itself, but said strike actions should be restricted in final-stage processes where there is a significant risk of product deterioration. “The union shall not cause its members or third parties to suspend work to prevent deterioration or spoilage of thawed cell lines during the strike period,” the ruling read. This means the union can stage a walkout in early-stage processes such as cell culture, purification and virus filtration, but not in finishing operations such as filling and concentration, where completed drug substances are processed into forms suitable for maintenance and storage. Article 38-2 of Korea’s Trade Union and Labor Relations Adjustment Act states that any work aimed at preventing raw materials or pro
Go to News Site